Description
JLL and CBRE are pleased to present a 100% freehold interest in 11-19 Riverview Place, Murarrie, part of the Core Life Science Portfolio, a defensive long-WALE offering comprising two high quality facilities located in Melbourne and Brisbane.
11-19 Riverview Place, Murarrie is a modern purpose-built life science facility within the Metroplex on Gateway Estate. The property comprises two buildings across adjoining sites, delivering high-quality laboratory, research and administrative accommodation with approximately 280 on-site car parking spaces.
Attributes
Media
Investment Highlights
- Long WALE of 9.2 years to QML Pathology, a subsidiary of Healius Limited.
- Mid-term market review in December 2030 (5% cap and collar).
- Substantial 2.38-hectare infill freehold landholding with 264m combined street frontage across Riverview Place and Metroplex Avenue.
- The facility operates as QML Pathology’s Queensland head office and central reference laboratory, an operationally critical asset that drives longterm tenant retention and sticky tenure.
- Strategically positioned within Brisbane's eastern corridor with direct Gateway Motorway (M1) access just 2km from the site.
- Expansion rights embedded in the lease, providing value-add potential in a severely supply-constrained market.
The Core Life Science Portfolio is being offered for sale Individually or In-One-Line via an Expressions of Interest Campaign closing at 3:00 PM (AEST) Thursday, 25th June 2026. For a copy of the information memorandum or to arrange an inspection, please contact the appointed sales agents at JLL and CBRE.
Contact brokers
